NCT03395197 2026-03-12
TALAPRO-2
Pfizer
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT07389187 2026-02-05
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07104643 2025-08-05
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
TYK Medicines, Inc
Phase 1/2 Not yet recruiting
NCT07096128 2025-07-31
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
Chinese PLA General Hospital
Phase 1 Recruiting
NCT06830408 2025-02-17
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study
University Hospital, Basel, Switzerland
Completed